E34.322
E34.322: Insulin-like growth factor-1 (IGF-1) resistance
Billable / specific codeICD-10-CM
E34.322 is a billable, specific ICD-10-CM code for insulin-like growth factor-1 (igf-1) resistance. It is valid for submission on a claim.
Check E34.322 with the rest of the claim: free scrubberInclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Genetic syndrome with resistance to insulin-like growth factor-1
- Insulin-like growth factor-1 receptor (IGF-1R) defect
- Post-insulin-like growth factor-1 receptor signaling defect
Excludes1 inherited from the categories above E34.322
A category’s note binds every code beneath it.
Written on E34.3: Short stature due to endocrine disorder
- achondroplastic short stature (Q77.4)
- hypochondroplastic short stature (Q77.4)
- nutritional short stature (E45)
- pituitary short stature (E23.0)
- progeria (E34.8)
- renal short stature (N25.0)
- Russell-Silver syndrome (Q87.19)
- short-limbed stature with immunodeficiency (D82.2)
- short stature (child) (R62.52)
- short stature in specific dysmorphic syndromes - code to syndrome - see Alphabetical Index
- short stature NOS (R62.52)
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
E34.322 is named in 1 Medicare coverage policy: 1 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A57204Billing and Coding: MRI and CT Scans of the Head and Neck
Alphabetic index entries that lead here
- Short, shortening, shortness›stature NEC›due to›genetic causes›genetic syndrome with resistance to insulin-like growth factor-1
- Short, shortening, shortness›stature NEC›due to›genetic causes›insulin-like growth factor-1 receptor defect(IGF-1R)
- Short, shortening, shortness›stature NEC›due to›genetic causes›insulin-like growth factor-1 resistance(IGF-1)
- Short, shortening, shortness›stature NEC›due to›genetic causes›post-insulin-like growth factor-1 receptor signaling defect
Code history
Unchanged in every release from FY2024 to FY2027.